News & Articles

August 23, 2017

Multiple sclerosis: Resistance training may reduce brain atrophy

Resistance training can benefit those with relapsing-remitting multiple sclerosis. Researchers found that engaging in resistance training twice per week for 6 months was associated with reduced brain […]
August 23, 2017

AbbVie’s Mavyret: The Hepatitis C Treatment We’ve Been Waiting For?

Mavyret is the newly approved hepatitis C medications. The Food and Drug Administration (FDA) recently approved AbbVie’s Mavyret, the newest treatment for chronic hepatitis C virus infection for […]
August 23, 2017

Cancer treatment: sorting the good news from the hype

How to determine which health information is valid. Every news story about cancer research should come with a health warning: believe the hope, but not the […]
August 22, 2017

How To Tell If You Should Get Screened For Lung Cancer 

It’s part of a new campaign from the American Lung Association Lung cancer is the leading cause of cancer death among men and women, partly because […]
August 22, 2017

FDA approves new drug to treat hepatitis C

There is a new medication for treating hepatitis C. Last week, the Food and Drug Administration approved the use of a new drug for treating all […]
August 21, 2017

Colon and rectal cancer deaths on the rise, study says 

Colon and rectal cancer deaths in younger people are on the rise. Adults in the United States are dying from colon and rectal cancers at an […]
August 21, 2017

CNS Inflammatory Diseases Make Stem Cells Ineffective in Treating MS, Study Says

Stem cell treatment doesn’t always work for multiple sclerosis. Pre-existing inflammatory diseases affecting the central nervous system make mesenchymal stem cells (MSCs) less effective in treating multiple sclerosis (MS), […]
August 21, 2017

FDA clears hepatitis C drug Mavyret

Mavyret, from AbbVie, joins the market to treat hepatitis C. The Food and Drug Administration has approved a new drug to treat adults with chronic hepatitis […]